Maverick Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,099
Closed -$509K 391
2022
Q2
$509K Buy
7,099
+3,557
+100% +$260K 0.01% 174
2022
Q1
$287K Buy
3,542
+2,756
+351% +$233K 0.01% 191
2021
Q4
$81K Buy
+786
New +$75.5K ﹤0.01% 258

Other funds holding SYNH

Maverick Capital's SYNH Position: Q3 2022 in Review

Maverick Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 7,099 shares — an estimated $509K sold.

Maverick Capital first reported a position in SYNH in Q4 2021 and held it in 3 quarters. The position peaked at $509K in Q2 2022. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

  • Maverick Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
  • Maverick Capital sold 7,099 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $509K.
  • Maverick Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2021 and held it in 3 quarters.
  • Maverick Capital's Syneos Health, Inc. Class A Common Stock position peaked at $509K in Q2 2022.
  • 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Maverick Capital's 13F filing for Q3 2022, filed 14 Nov 2022.